Although two-dose mRNA vaccination provides excellent protection against SARS-CoV-2,
there is little information about vaccine efficacy against variants of concern (VOC) in …

The kinetics of the immune changes in COVID-19 across severity groups have not been
rigorously assessed. Using immunophenotyping, RNA sequencing, and serum cytokine analysis…

The biology driving individual patient responses to severe acute respiratory syndrome
coronavirus 2 infection remains ill understood. Here, we developed a patient-centric framework …

B cells are important in immunity to both severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
infection and vaccination, but B cell receptor (BCR) repertoire development in …

Tumor necrosis factor receptor–associated factor 3 (TRAF3) is a central regulator of immunity.
TRAF3 is often somatically mutated in B cell malignancies, but its role in human immunity …

Autoimmune vasculitis is a group of life-threatening diseases, whose underlying pathogenic
mechanisms are incompletely understood, hampering development of targeted therapies. …

Background Prominent early features of COVID-19 include severe, often clinically silent,
hypoxia and a pronounced reduction in B cells, the latter important in defence against SARS-…

Persistent symptoms following SARS-CoV-2 infection are increasingly reported, although
the drivers of post-acute sequelae (PASC) of COVID-19 are unclear. Here we assessed 214 …

Autism is thought to be a neurodevelopmental disorder with symptoms developing during
neonatal neurogenesis in the subventricular zone (SVZ). Autism associated genes alter SVZ …

In a study of 207 SARS-CoV2-infected individuals with a range of severities followed over 12
weeks from symptom onset, we demonstrate that an early robust immune response, without …